Fig 1.
Frequencies of comorbidities according to AF type.
TIA, transient ischemic attack; DVT, deep vein thrombosis; OSAS, obstructive sleep apnoea syndrome; PAD, peripheral artery disease.
Table 1.
Baseline characteristics according to AF type.
BMI, body mass index; NOACs, new oral anticoagulants; MoCA, Montreal Cognitive Assessment.
Table 2.
Symptoms and EHRA Score according to AF type.
EHRA, European Heart Rhythm Association.
Table 3.
EQ-5D-EU-Utilities and VAS Scores according to AF type.
Table 4.
Multivariable regression analysis: Predictors of utility in AF patients.
Joint p values: AF type p = 0.054, age p<0.001, EHRA Score p = 0.001, Education level p = 0.004. Study centre was included as a random effect variable in the model. OSAS, obstructive sleep apnoea syndrome; PAD, peripheral artery disease; DVT, deep vein thrombosis; EHRA, European Heart Rhythm Association.
Table 5.
Multivariable regression analysis: Predictors of the VAS score in AF patients.
Joint p values: AF type p = 0.634, age p<0.001, EHRA Score p<0.001, Education level p = 0.010. Study centre was included as random effect in the model. OSAS, obstructive sleep apnoea syndrome; PAD, peripheral artery disease; DVT, deep vein thrombosis; TIA, transient ischemic attack; EHRA, European Heart Rhythm Association; PVI, pulmonary vein isolation.
Fig 2.
Boxplots of utility and VAS score according to the EHRA class.
Fig 3.
Distribution of utility and VAS score in the study population.